Sumitomo Pharma Co. Ltd.

In News

Why Sumitomo Pharma Co. Ltd. (DPM) stock could rally strongly - July 2025 Volume & Consistent Profit Trading Strategies - Newser

Newser - Dec 05, 2025

Sumitomo Pharma America Announces that the European Medicines Agency Has Granted Orphan Drug Designation to Nuvisertib (TP-3654) for the Treatment of Myelofibrosis - PR Newswire

PR Newswire - Jul 30, 2025

Establishment of a Pharmaceutical Strategic Platform： Succession of Sumitomo Pharma’s Business in Asia - marubeni.com

marubeni.com - Apr 01, 2025

Investing in Sumitomo Pharma (TSE:4506) a year ago would have delivered you a 350% gain - simplywall.st

simplywall.st - Dec 01, 2025

Sumitomo Pharma : Announces Personnel Change - marketscreener.com

marketscreener.com - Dec 01, 2025

Sumitomo Pharma’s Comeback Story: Reinventing a Century-Old Giant in a Post-Patent Era - geneonline.com

geneonline.com - Apr 22, 2025

Knight Therapeutics and Sumitomo Pharma enter into Exclusive Licensing Agreements to commercialize Sumitomo’s Canadian Portfolio - Yahoo Finance

Yahoo Finance - Jun 05, 2025

Will Sumitomo Pharma Co. Ltd. (DPM) stock outperform energy sector in 2025 - July 2025 Trends & Community Consensus Picks - Newser

Newser - Dec 04, 2025

Earnings call transcript: Sumitomo Dainippon Pharma Q1 2025 sees strong North American sales - Investing.com

Investing.com - Oct 14, 2025

Sumitomo Pharma Completes Asian Business Transfer to Marubeni - The Globe and Mail

The Globe and Mail - Aug 01, 2025

Sumitomo Pharma Poised to Jump on Stem Cell Research Results - Bloomberg.com

Bloomberg.com - Apr 17, 2025

What drives Sumitomo Pharma Co Ltd DPM stock price - VWAP Trading Strategies & Master Stock Selection - earlytimes.in

earlytimes.in - Dec 04, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment